Data from the pivotal Phase 2b ReNeu trial demonstrate that patients with NF1-PN achieved deep responses and improvements in ...

A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.

Nomlabofusp program update expected mid-December to include available safety, pharmacokinetic (PK) and frataxin data, as well as available ...

Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, today announced the publication of ...

"We are thrilled to present preclinical data for ZW220 and ZW251 at the EORTC-NCI-AACR Conference," said Paul Moore, Ph.D., ...

On track to start dosing in pivotal, adaptive Phase 3 clinical trial (the "MIRACLE" trial) designed for possible accelerated approval of Annamycin in combination with cytarabine for the treatment of R ...

Despite a PlayStation blog earlier this year that suggested Metal Gear Solid Delta: Snake Eater would drop in 2024, Konami still hasn't put a definite release date against the highly-anticipated ...

Your browser does not support the audio element. MG Motor has released the first set of images and details of an all-new ES5 electric SUV. The ES5 will be a global ...

MG published the first photos of the ES5, a fully electric SUV for global markets. The ES5 will replace the MG ZS EV, with a larger footprint and modern technology. The MG4-based SUV is powered by ...

Financing provides Alirio Torrealba’s firm with time to refine plans and complete construction drawings for Alhambra Parc, a planned 11-story building with 78 units From left: MG Developer’s ...

Ascentage Pharma, a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies.